Narrative review / 2016
Pharmacotherapies and food components like thylakoids show potential for targeting reward-induced eating and food cravings.
This narrative review examines appetite and reward-induced eating behavior, noting that cravings triggered by food cues activate mesocorticolimbic dopamine pathways and affect weight outcomes. Approved weight-management medications, including naltrexone-bupropion, lorcaserin, liraglutide, and phentermine, show promise or preliminary efficacy in targeting craving-related eating behavior. Additionally, food components such as thylakoid membranes have been shown to influence food cravings.
- Study type
- Narrative review
- Who was studied
- Individuals with reward-induced eating and food cravings
- What was measured
- Effects of pharmacological agents and food components on food cravings
THE PAPER
Reward-Induced Eating: Therapeutic Approaches to Addressing Food Cravings.
Rebello CJ, Greenway FL. Adv Ther, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.